$BKNG
Booking Holdings Inc.

2023 Q2 Form 10-Q Financial Statement

#000107553123000031 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $5.462B $3.778B $2.695B
YoY Change 27.2% 40.19% 136.2%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.667B $1.806B $1.305B
YoY Change 88.63% 38.39% 125.0%
% of Gross Profit
Research & Development $144.0M $137.0M $134.0M
YoY Change 5.11% 2.24% 54.02%
% of Gross Profit
Depreciation & Amortization $121.0M $120.0M $111.0M
YoY Change 13.08% 8.11% -1.77%
% of Gross Profit
Operating Expenses $3.788B $3.328B $2.521B
YoY Change 15.0% 32.01% 73.62%
Operating Profit $1.673B $450.0M $174.0M
YoY Change 67.3% 158.62% -155.95%
Interest Expense -$57.00M $194.0M $68.00M
YoY Change -175.0% 185.29% -30.61%
% of Operating Profit -3.41% 43.11% 39.08%
Other Income/Expense, Net $2.000M $47.00M -$955.0M
YoY Change -99.09% -104.92% -829.01%
Pretax Income $1.618B $303.0M -$849.0M
YoY Change 41.43% -135.69% 205.4%
Income Tax $328.0M $37.00M -$149.0M
% Of Pretax Income 20.27% 12.21%
Net Earnings $1.290B $266.0M -$700.0M
YoY Change 50.53% -138.0% 1172.73%
Net Earnings / Revenue 23.62% 7.04% -25.97%
Basic Earnings Per Share $35.16 $7.07 -$17.10
Diluted Earnings Per Share $34.90 $7.00 -$17.10
COMMON SHARES
Basic Shares Outstanding 36.93M shares 37.65M shares 40.92M shares
Diluted Shares Outstanding 36.96M shares 37.98M shares 40.92M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.24B $14.50B $10.55B
YoY Change 28.72% 37.44% -16.62%
Cash & Equivalents $14.60B $14.14B $10.55B
Short-Term Investments $640.0M $359.0M
Other Short-Term Assets $1.302B $430.0M $320.0M
YoY Change 280.7% 34.38% -45.3%
Inventory
Prepaid Expenses $849.0M $655.0M $395.0M
Receivables $2.805B $2.048B $1.611B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.35B $17.63B $12.88B
YoY Change 29.65% 36.95% -8.74%
LONG-TERM ASSETS
Property, Plant & Equipment $1.340B $699.0M $844.0M
YoY Change 56.18% -17.18% 14.99%
Goodwill $2.821B $2.816B $2.878B
YoY Change -0.74% -2.15% 52.92%
Intangibles $1.722B $1.777B $1.997B
YoY Change -10.55% -11.02% 13.34%
Long-Term Investments $440.0M $806.0M $2.200B
YoY Change -81.52% -63.36% -41.92%
Other Assets $886.0M $854.0M $1.103B
YoY Change -20.75% -22.57% 22.42%
Total Long-Term Assets $7.209B $7.574B $9.509B
YoY Change -24.66% -20.35% -0.4%
TOTAL ASSETS
Total Short-Term Assets $19.35B $17.63B $12.88B
Total Long-Term Assets $7.209B $7.574B $9.509B
Total Assets $26.56B $25.21B $22.38B
YoY Change 8.43% 12.61% -5.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.123B $2.132B $1.504B
YoY Change -5.22% 41.76% 163.86%
Accrued Expenses $3.463B $3.584B $1.876B
YoY Change 46.49% 91.04% 38.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $855.0M $854.0M $1.333B
YoY Change -33.36% -35.93% -65.86%
Total Short-Term Liabilities $12.48B $11.07B $7.478B
YoY Change 21.39% 48.03% 15.62%
LONG-TERM LIABILITIES
Long-Term Debt $13.20B $11.27B $8.435B
YoY Change 61.15% 33.63% -15.06%
Other Long-Term Liabilities $1.206B $172.0M $203.0M
YoY Change 570.0% -15.27% 58.59%
Total Long-Term Liabilities $14.40B $11.44B $8.638B
YoY Change 72.09% 32.48% -14.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.48B $11.07B $7.478B
Total Long-Term Liabilities $14.40B $11.44B $8.638B
Total Liabilities $27.22B $24.13B $18.01B
YoY Change 32.85% 33.98% -4.66%
SHAREHOLDERS EQUITY
Retained Earnings $29.10B $27.81B $23.78B
YoY Change 18.09% 16.92% 2.37%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $36.32B $33.18B $25.39B
YoY Change 36.21% 30.67% 4.6%
Treasury Stock Shares 23.00M shares
Shareholders Equity -$665.0M $1.074B $4.373B
YoY Change
Total Liabilities & Shareholders Equity $26.56B $25.21B $22.38B
YoY Change 8.43% 12.61% -5.37%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.290B $266.0M -$700.0M
YoY Change 50.53% -138.0% 1172.73%
Depreciation, Depletion And Amortization $121.0M $120.0M $111.0M
YoY Change 13.08% 8.11% -1.77%
Cash From Operating Activities $1.737B $2.889B $1.695B
YoY Change -35.28% 70.44% -918.84%
INVESTING ACTIVITIES
Capital Expenditures $92.00M $88.00M $109.0M
YoY Change -206.98% -19.27% 67.69%
Acquisitions
YoY Change
Other Investing Activities $53.00M $9.000M -$12.00M
YoY Change -247.22% -175.0%
Cash From Investing Activities -$39.00M $1.586B -$121.0M
YoY Change -68.03% -1410.74% 86.15%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $1.049B
YoY Change 665.69%
Debt Paid & Issued, Net $500.0M $1.102B
YoY Change -54.63%
Cash From Financing Activities -1.225B -$2.562B -$2.139B
YoY Change -1.05% 19.78% -214.45%
NET CHANGE
Cash From Operating Activities 1.737B $2.889B $1.695B
Cash From Investing Activities -39.00M $1.586B -$121.0M
Cash From Financing Activities -1.225B -$2.562B -$2.139B
Net Change In Cash 473.0M $1.921B -$574.0M
YoY Change -64.27% -434.67% -136.1%
FREE CASH FLOW
Cash From Operating Activities $1.737B $2.889B $1.695B
Capital Expenditures $92.00M $88.00M $109.0M
Free Cash Flow $1.645B $2.801B $1.586B
YoY Change -40.61% 76.61% -683.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001075531
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-36691
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Booking Holdings Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1528493
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
800 Connecticut Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Norwalk
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06854
CY2023Q1 dei City Area Code
CityAreaCode
203
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
299-8000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36933652 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14140000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12221000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
359000000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
175000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
93000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117000000 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2048000000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2229000000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
655000000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
477000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
430000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
696000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
17632000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
15798000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3584000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3244000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
699000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
669000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
622000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
645000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1777000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1829000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2816000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2807000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
806000000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2789000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
854000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
824000000 usd
CY2023Q1 us-gaap Assets
Assets
25206000000 usd
CY2022Q4 us-gaap Assets
Assets
25361000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2132000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2507000000 usd
CY2023Q1 bkng Deferred Merchant Bookings
DeferredMerchantBookings
4500000000 usd
CY2022Q4 bkng Deferred Merchant Bookings
DeferredMerchantBookings
2223000000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
854000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
500000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11070000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8474000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
368000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
685000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
539000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
552000000 usd
CY2023Q1 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent
711000000 usd
CY2022Q4 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent
711000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
172000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
172000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11272000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11985000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
24132000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
22579000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.008
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.008
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64008335 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63780528 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26796116 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
25917558 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
33178000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
30983000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6712000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6491000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27807000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27541000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-267000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-267000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1074000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2782000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25206000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25361000000 usd
CY2023Q1 us-gaap Revenues
Revenues
3778000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2695000000 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
1517000000 usd
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
1147000000 usd
CY2023Q1 bkng Salesandotherexpenses
Salesandotherexpenses
542000000 usd
CY2022Q1 bkng Salesandotherexpenses
Salesandotherexpenses
339000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113000000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93000000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
722000000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
596000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
289000000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158000000 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
137000000 usd
CY2022Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
134000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
120000000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111000000 usd
CY2023Q1 bkng Restructuring Disposal And Other Exit Activities
RestructuringDisposalAndOtherExitActivities
1000000 usd
CY2022Q1 bkng Restructuring Disposal And Other Exit Activities
RestructuringDisposalAndOtherExitActivities
36000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3328000000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2521000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
450000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
174000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
194000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
68000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-955000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
303000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-849000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-149000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-700000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-17.10
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37621000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40921000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-17.10
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37983000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40921000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-700000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-38000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
266000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-739000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2782000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
105000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2195000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1074000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6178000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-700000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-38000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1100000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4373000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-700000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111000000 usd
CY2023Q1 bkng Provision For Expected Credit Losses And Chargebacks
ProvisionForExpectedCreditLossesAndChargebacks
54000000 usd
CY2022Q1 bkng Provision For Expected Credit Losses And Chargebacks
ProvisionForExpectedCreditLossesAndChargebacks
55000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-340000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-216000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-133000000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-987000000 usd
CY2023Q1 bkng Share Based Compensation And Other Stock Based Expense
ShareBasedCompensationAndOtherStockBasedExpense
113000000 usd
CY2022Q1 bkng Share Based Compensation And Other Stock Based Expense
ShareBasedCompensationAndOtherStockBasedExpense
93000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
41000000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
39000000 usd
CY2023Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
-26000000 usd
CY2022Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
30000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-30000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-158000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
326000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
56000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
2038000000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
1868000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-162000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
160000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2889000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1695000000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1683000000 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
109000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
9000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
12000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1586000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1102000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2150000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1049000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
105000000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
9000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2562000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2139000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1921000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-574000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12251000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11152000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14172000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10578000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
311000000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
98000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
142000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
72000000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from prior periods have been reclassified to conform to the current period presentation.</span></div>
CY2023Q1 us-gaap Revenues
Revenues
3778000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2695000000 usd
CY2023Q1 bkng Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantDateFairValue
555000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
401000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
89000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37621000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40921000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
242000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
120000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37983000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40921000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58079 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
269653 shares
CY2023Q1 bkng Short Term Investments Cost
ShortTermInvestmentsCost
363000000 usd
CY2023Q1 bkng Short Term Investments Gross Unrealized Gain
ShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q1 bkng Short Term Investments Gross Unrealized Loss
ShortTermInvestmentsGrossUnrealizedLoss
4000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
359000000 usd
CY2023Q1 bkng Longterminvestmentcost
Longterminvestmentcost
1167000000 usd
CY2023Q1 bkng Longterminvestmentgrossunrealizedgain
Longterminvestmentgrossunrealizedgain
259000000 usd
CY2023Q1 bkng Longterminvestmentgrossunrealizedloss
Longterminvestmentgrossunrealizedloss
620000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
806000000 usd
CY2022Q4 bkng Short Term Investments Cost
ShortTermInvestmentsCost
176000000 usd
CY2022Q4 bkng Short Term Investments Gross Unrealized Gain
ShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2022Q4 bkng Short Term Investments Gross Unrealized Loss
ShortTermInvestmentsGrossUnrealizedLoss
1000000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
175000000 usd
CY2022Q4 bkng Longterminvestmentcost
Longterminvestmentcost
1819000000 usd
CY2022Q4 bkng Longterminvestmentgrossunrealizedgain
Longterminvestmentgrossunrealizedgain
1611000000 usd
CY2022Q4 bkng Longterminvestmentgrossunrealizedloss
Longterminvestmentgrossunrealizedloss
641000000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2789000000 usd
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-17000000 usd
CY2022Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-16000000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1400000000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1500000000 usd
CY2023Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
601000000 usd
CY2022Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
730000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117000000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
101000000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
30000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
45000000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
28000000 usd
CY2023Q1 bkng Accounts Receivable Allowance For Credit Loss Foreign Currency Translation Adjustment Increase Decrease
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustmentIncreaseDecrease
1000000 usd
CY2022Q1 bkng Accounts Receivable Allowance For Credit Loss Foreign Currency Translation Adjustment Increase Decrease
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustmentIncreaseDecrease
-1000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
93000000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
102000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3522000000 usd
CY2022Q4 bkng Contract With Customer Asset Prepayments To Customers Allowance For Credit Loss
ContractWithCustomerAssetPrepaymentsToCustomersAllowanceForCreditLoss
23000000 usd
CY2021Q4 bkng Contract With Customer Asset Prepayments To Customers Allowance For Credit Loss
ContractWithCustomerAssetPrepaymentsToCustomersAllowanceForCreditLoss
47000000 usd
CY2023Q1 bkng Contract With Customer Asset Prepayments To Customers Provision Charged To Expense
ContractWithCustomerAssetPrepaymentsToCustomersProvisionChargedToExpense
0 usd
CY2022Q1 bkng Contract With Customer Asset Prepayments To Customers Provision Charged To Expense
ContractWithCustomerAssetPrepaymentsToCustomersProvisionChargedToExpense
3000000 usd
CY2023Q1 bkng Contract With Customer Asset Prepayments To Customers Write Offs
ContractWithCustomerAssetPrepaymentsToCustomersWriteOffs
2000000 usd
CY2022Q1 bkng Contract With Customer Asset Prepayments To Customers Write Offs
ContractWithCustomerAssetPrepaymentsToCustomersWriteOffs
1000000 usd
CY2023Q1 bkng Contract With Customer Asset Prepayments To Customers Allowance For Credit Loss
ContractWithCustomerAssetPrepaymentsToCustomersAllowanceForCreditLoss
21000000 usd
CY2022Q1 bkng Contract With Customer Asset Prepayments To Customers Allowance For Credit Loss
ContractWithCustomerAssetPrepaymentsToCustomersAllowanceForCreditLoss
43000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3533000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1756000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1777000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1693000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1829000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56000000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2000000000 usd
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2000000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
21900000000 usd
CY2023Q1 bkng Stock Repurchase Program Expected Time To Complete
StockRepurchaseProgramExpectedTimeToComplete
P4Y
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
66000 shares
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
173000000 usd
CY2022Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
73000 shares
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
152000000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
878000 shares
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2195000000 usd
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
487000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1100000000 usd
CY2023Q1 bkng Treasury Stock Repurchased But Unsettled By Period End Amount
TreasuryStockRepurchasedButUnsettledByPeriodEndAmount
100000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
158000000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
131000000 usd
CY2023Q1 bkng Partner Liability Insurance Maximum
PartnerLiabilityInsuranceMaximum
1000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.124
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.176
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
184000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
43000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39000000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
228000000 usd
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-133000000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-987000000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-53000000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
30000000 usd
CY2023Q1 bkng Other Nonoperating Income Expense Other Miscellaneous Amounts
OtherNonoperatingIncomeExpenseOtherMiscellaneousAmounts
5000000 usd
CY2022Q1 bkng Other Nonoperating Income Expense Other Miscellaneous Amounts
OtherNonoperatingIncomeExpenseOtherMiscellaneousAmounts
-1000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-955000000 usd
CY2023Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
-26000000 usd
CY2022Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
30000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14140000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12221000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
32000000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
30000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14172000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12251000000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000000 usd

Files In Submission

Name View Source Status
bkng-20230331_htm.xml Edgar Link completed
bkng-20230331_def.xml Edgar Link unprocessable
0001075531-23-000031-index-headers.html Edgar Link pending
0001075531-23-000031-index.html Edgar Link pending
0001075531-23-000031.txt Edgar Link pending
0001075531-23-000031-xbrl.zip Edgar Link pending
bkng-20230331.htm Edgar Link pending
bkng-20230331.xsd Edgar Link pending
bkng-20230331_g1.jpg Edgar Link pending
bkng-20230331_g2.jpg Edgar Link pending
bkng33123ex311.htm Edgar Link pending
bkng33123ex312.htm Edgar Link pending
bkng33123ex321.htm Edgar Link pending
bkng33123ex322.htm Edgar Link pending
ex101creditagreementamendm.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
bkng-20230331_cal.xml Edgar Link unprocessable
bkng-20230331_pre.xml Edgar Link unprocessable
bkng-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending